The EU product label for Tarceva can be found on the EMEA SmPC internet page.
The EU product label for Tarceva is available in different languages.
Click to access and download the new Tarceva mechanism of action video.
Tarceva is now approved for first-line therapy of EGFR Mut+ NSCLC.
Click to view, download or print our MoA, dosing and disease state materials.
This site is only intended for use by healthcare professionals outside of the US. If you are a US resident, please visit www.tarceva.com.